SCHEMBL15910975

SCHEMBL15910975

C=CC(=O)OCCCCCOc1c(OC)cccc1OC

nearest known ligand 0.56

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ SMN1; SMN2 Q16637 5/20 0.56
▸ ALDH1A1 P00352 5/20 0.54
▸ TSHR P16473 3/20 0.54
▸ CYP3A4 P08684 1/20 0.54
▸ THRB P10828 1/20 0.47
▸ HPGD P15428 2/20 0.46
▸ LMNA P02545 4/20 0.46
▸ L3MBTL1 Q9Y468 2/20 0.46
▸ MAPT P10636 2/20 0.46
▸ GAA P10253 1/20 0.46
▸ MEN1 O00255 3/20 0.46
▸ KMT2A Q03164 3/20 0.46
▸ CYP1A2 P05177 1/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ ATM Q13315 1/20 0.45
▸ KDM4E B2RXH2 2/20 0.44
▸ MAPK1 P28482 1/20 0.43
▸ NPC1 O15118 1/20 0.42
▸ RAB9A P51151 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15910611 1.00 SMN1; SMN2 (0.56) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910762 0.99 SMN1; SMN2 (0.57) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910689 0.96 SMN1; SMN2 (0.62) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910968 0.91 THRB (0.56) SMN1; SMN2ALDH1A1TSHRTHRBLMNA
SCHEMBL1248482 0.88 SMN1; SMN2 (0.46) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910857 0.87 LMNA (0.60) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910745 0.87 LMNA (0.60) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL15910880 0.85 LMNA (0.61) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL28412639 0.82 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB
SCHEMBL28403928 0.82 ALDH1A1 (0.44) SMN1; SMN2ALDH1A1TSHRCYP3A4THRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2762506-B1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2022-09-07 — — EP disclosed
US-9708424-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2017-07-18 — — US disclosed
US-20170051093-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORP (JP) 2017-02-23 — — US disclosed
US-9512247-B2 (Meth)acryloyl-terminated polyisobutylene polymer, method for producing the same, and active energy ray-curable composition KANEKA CORPORATION (JP) 2016-12-06 — — US disclosed
US-20140243444-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING THE SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION KANEKA CORPORATION (JP) 2014-08-28 — — US disclosed
EP-2762506-A1 (METH)ACRYLOYL-TERMINATED POLYISOBUTYLENE POLYMER, METHOD FOR PRODUCING SAME, AND ACTIVE ENERGY RAY-CURABLE COMPOSITION Kaneka Corporation (JP) 2014-08-06 — — EP disclosed
Send feedback